DarioHealth Corp. Financial Ratios
DRIO|FY2018 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2018 SEC 10-K data.
Key Data Points
- Altman Z-Score -2.24 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2018)
Return on Equity
-399.5%
Profit Margin
-304.5%
Net Income / Revenue
Asset Turnover
0.37
Revenue / Total Assets
Equity Multiplier
3.57
Total Assets / Equity
Composite: -399.5% (reported: -399.5%)
Profitability
Liquidity
Current Ratio
2.58
Quick Ratio
2.31
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.37
Inventory Turnover
2.80
Days Sales Outstanding
-
As of FY2018 · SEC 10-K Annual Filings · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-48.7%
-12.6pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.